Showing 1 - 10 results of 10 for search 'Carl Friedrich Classen', query time: 0.04s Refine Results
  1. 1
    Splenomegaly in Children and Adolescents

    Splenomegaly in Children and Adolescents by Meinolf Suttorp, Meinolf Suttorp, Carl Friedrich Classen

    Published 2021-07-01
    Get full text
    Article
  2. 2
    Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.

    Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma. by Doreen William, Madlin Walther, Björn Schneider, Michael Linnebacher, Carl Friedrich Classen

    Published 2018-01-01
    Get full text
    Article
  3. 3
    Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: a detailed comparison.

    Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: a detailed comparison. by Christina Susanne Mullins, Björn Schneider, Florian Stockhammer, Mathias Krohn, Carl Friedrich Classen, Michael Linnebacher

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies

    Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies by Christin Riess, Fatemeh Shokraie, Carl Friedrich Classen, Bernd Kreikemeyer, Tomas Fiedler, Christian Junghanss, Claudia Maletzki

    Published 2018-11-01
    Get full text
    Article
  5. 5
    Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme.

    Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme. by Doreen William, Poroshista Mokri, Nora Lamp, Michael Linnebacher, Carl Friedrich Classen, Andreas Erbersdobler, Björn Schneider

    Published 2017-01-01
    Get full text
    Article
  6. 6
    Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models

    Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models by Christin Riess, Dirk Koczan, Björn Schneider, Charlotte Linke, Katharina del Moral, Carl Friedrich Classen, Claudia Maletzki

    Published 2021-03-01
    Get full text
    Article
  7. 7
    Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib

    Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib by Christin Riess, Christin Riess, Christin Riess, Björn Schneider, Hanna Kehnscherper, Julia Gesche, Nina Irmscher, Fatemeh Shokraie, Carl Friedrich Classen, Elisa Wirthgen, Grazyna Domanska, Annette Zimpfer, Daniel Strüder, Christian Junghanss, Claudia Maletzki

    Published 2020-02-01
    Get full text
    Article
  8. 8
    The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C

    The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C by Charlotte Linke, Thomas Freitag, Christin Riess, Jana Vanessa Scheffler, Katharina del Moral, Nina Schoenwaelder, Tomas Fiedler, Adina Fiebig, Philipp Kaps, Daniel Dubinski, Björn Schneider, Wendy Bergmann, Carl Friedrich Classen, Claudia Maletzki

    Published 2023-02-01
    Get full text
    Article
  9. 9
    Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells

    Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells by Christin Riess, Katharina del Moral, Adina Fiebig, Philipp Kaps, Charlotte Linke, Burkhard Hinz, Anne Rupprecht, Marcus Frank, Tomas Fiedler, Dirk Koczan, Sascha Troschke-Meurer, Holger N. Lode, Nadja Engel, Thomas Freitag, Carl Friedrich Classen, Claudia Maletzki

    Published 2022-06-01
    Get full text
    Article
  10. 10
    Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up

    Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up by Georg Seifert, Sarah B. Blakeslee, Gabriele Calaminus, Farid I. Kandil, Andrea Barth, Toralf Bernig, Carl Friedrich Classen, Selim Corbacioglu, Jürgen Föll, Sven Gottschling, Bernd Gruhn, Claudia vom Hoff-Heise, Holger N. Lode, David Martin, Michaela Nathrath, Felix Neunhoeffer, Arnulf Pekrun, Beate Wulff, Tycho Zuzak, Günter Henze, Alfred Längler

    Published 2022-06-01
    Get full text
    Article

Search Tools: